Tissue N-linked glycosylation as potential prognostic biomarker for biochemical recurrence-free survival

References

• Abugharib, A., et al., 2017. Very early salvage radiotherapy improves distant metastasis-free survival. Journal of urology, 197 (3 Part 1), 662–668.
   PubMed Web of Science ®Google Scholar
• Antonarakis, E.S., et al., 2012. The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-up. BJU international, 109 (1), 32–39.
   PubMed Web of Science ®Google Scholar
• Bastian, P.J., et al., 2007. Prognostic value of preoperative serum cell-free circulating DNA in men with prostate cancer undergoing radical prostatectomy. Clinical cancer research, 13 (18), 5361–5367.
   PubMed Web of Science ®Google Scholar
• Cornford, P., et al., 2017. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer. European urology, 71 (4), 630–642.
   PubMed Web of Science ®Google Scholar
• Di Zazzo, E., et al., 2016. Prostate cancer stem cells: the role of androgen and estrogen receptors. Oncotarget, 7 (1), 193–208.
   PubMedGoogle Scholar
• Diaz, M., et al., 2015. Oncologic outcomes at 10 years following robotic radical prostatectomy. European urology, 67 (6), 1168–1176.
   PubMed Web of Science ®Google Scholar
• Eisenberg, M.L., et al., 2010. Prognostic implications of an undetectable ultrasensitive prostate-specific antigen level after radical prostatectomy. European urology, 57 (4), 622–629.
   PubMed Web of Science ®Google Scholar
• Ferlay, J., et al., 2018. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. European journal of cancer (Oxford, England : 1990), 103, 356–387.
   PubMed Web of Science ®Google Scholar
• Gala, F.A., et al., 2002. The role of constant region carbohydrate in the assembly and secretion of human IgD and IgA1. The journal of biological chemistry, 277 (32), 29005–29011.
   PubMed Web of Science ®Google Scholar
• Hagiwara, K., et al., 2017. Wisteria floribunda agglutinin and its reactive-glycan-carrying prostate-specific antigen as a novel diagnostic and prognostic marker of prostate cancer. International journal of molecular sciences, 18 (2), 261.
   Web of Science ®Google Scholar
• Holmes, E.E., et al., 2016. PITX3 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients after radical prostatectomy. Clinical epigenetics, 8, 104.
   PubMed Web of Science ®Google Scholar
• Inman, B.A., et al., 2011. Dynamic prediction of metastases after radical prostatectomy for prostate cancer. BJU international, 108 (11), 1762–1768.
   PubMed Web of Science ®Google Scholar
• Kumar, S., et al., 2006. Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer. Cochrane database of systematic reviews, CD006019.
   PubMed Web of Science ®Google Scholar
• Lange, T., et al., 2012. Human prostate cancer in a clinically relevant xenograft mouse model: identification of beta(1,6)-branched oligosaccharides as a marker of tumor progression. Clinical cancer research, 18 (5), 1364–1373.
   PubMed Web of Science ®Google Scholar
• Le, J.D., et al., 2015. Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging: correlation with whole-mount histopathology. European urology, 67 (3), 569–576.
   PubMed Web of Science ®Google Scholar
• Llop, E., et al., 2016. Improvement of prostate cancer diagnosis by detecting PSA glycosylation-specific changes. Theranostics, 6 (8), 1190–1204.
   PubMed Web of Science ®Google Scholar
• Mottet, N., et al., 2017. EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. European urology, 71 (4), 618–629.
   PubMed Web of Science ®Google Scholar
• Moul, J.W., et al., 2004. Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomy. Journal of urology, 171 (3), 1141–1147.
   PubMed Web of Science ®Google Scholar
• Nagae, M., et al., 2018. Structure and mechanism of cancer-associated N-acetylglucosaminyltransferase-V. Nature communications, 9 (1), 3380.
   PubMedGoogle Scholar
• Nyalwidhe, J.O., et al., 2013. Increased bisecting N-acetylglucosamine and decreased branched chain glycans of N-linked glycoproteins in expressed prostatic secretions associated with prostate cancer progression. Proteomics. Clinical applications, 7 (9-10), 677–689.
   PubMed Web of Science ®Google Scholar
• Orsonneau, J.L., et al., 1989. An improved pyrogallol red-molybdate method for determining total urinary protein. Clinical chemistry, 35 (11), 2233–2236.
   PubMed Web of Science ®Google Scholar
• Paradis, V., 2005. Glycomics: a new taste of cirrhosis marker. Journal of hepatology, 43 (5), 913–914.
   PubMedGoogle Scholar
• Roehl, K.A., et al., 2004. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results. Journal of urology, 172 (3), 910–914.
   PubMed Web of Science ®Google Scholar
• Saldova, R., et al., 2011. Core fucosylation and alpha2-3 sialylation in serum N-glycome is significantly increased in prostate cancer comparing to benign prostate hyperplasia. Glycobiology, 21 (2), 195–205.
   PubMed Web of Science ®Google Scholar
• Scott, E., et al., 2019. Glycans as biomarkers in prostate cancer. International journal of molecular sciences., 20, 1389.
   Web of Science ®Google Scholar
• Shen, S., et al., 2005. Ultrasensitive serum prostate specific antigen nadir accurately predicts the risk of early relapse after radical prostatectomy. Journal of urology, 173 (3), 777–780.
   PubMed Web of Science ®Google Scholar
• Sooriakumaran, P., et al., 2012. Biochemical recurrence after robot-assisted radical prostatectomy in a European single-centre cohort with a minimum follow-up time of 5 years. European urology, 62 (5), 768–774.
   PubMed Web of Science ®Google Scholar
• Taylor, J.A., 3rd., et al., 2006. The relationship of ultrasensitive measurements of prostate-specific antigen levels to prostate cancer recurrence after radical prostatectomy. BJU international, 98 (3), 540–543.
   PubMed Web of Science ®Google Scholar
• Tilki, D., et al., 2017. Adjuvant radiation therapy is associated with better oncological outcome compared with salvage radiation therapy in patients with pN1 prostate cancer treated with radical prostatectomy. BJU international, 119 (5), 717–723.
   PubMed Web of Science ®Google Scholar
• Tilki, D., et al., 2019. External Validation of the European Association of Urology Biochemical Recurrence Risk Groups to Predict Metastasis and Mortality After Radical Prostatectomy in a European Cohort. European urology, 75 (6), 896–900.
   PubMed Web of Science ®Google Scholar
• Van den Broeck, T., et al., 2019. Prognostic value of biochemical recurrence following treatment with curative intent for prostate cancer: a systematic review. European urology, 75 (6), 967–987.
   PubMed Web of Science ®Google Scholar
• Van den Broeck, T., et al., 2020. Biochemical recurrence in prostate cancer: the European Association of Urology Prostate Cancer Guidelines Panel Recommendations. European urology focus, 6 (2), 231–234.
   PubMedGoogle Scholar
• Vermassen, T., et al., 2012. Glycosylation of prostate specific antigen and its potential diagnostic applications. Clinica chimica acta; international journal of clinical chemistry, 413 (19-20), 1500–1505.
   PubMed Web of Science ®Google Scholar
• Vermassen, T., et al., 2014. Capillary electrophoresis of urinary prostate glycoproteins assists in the diagnosis of prostate cancer. Electrophoresis, 35 (7), 1017–1024.
   PubMed Web of Science ®Google Scholar
• Vermassen, T., et al., 2015a. Diagnostic accuracy of urinary prostate protein glycosylation profiling in prostatitis diagnosis. Biochemia medica, 25, 439–449.
   Web of Science ®Google Scholar
• Vermassen, T., et al., 2015b. Urinary prostate protein glycosylation profiling as a diagnostic biomarker for prostate cancer. The prostate, 75 (3), 314–322.
   PubMed Web of Science ®Google Scholar
• Vermassen, T., et al., 2019a. N-Linked glycosylation and near-infrared spectroscopy in the diagnosis of prostate cancer. International journal of molecular sciences, 20, 1592.
   Web of Science ®Google Scholar
• Vermassen, T., et al., 2019b. Prostate protein N-glycosylation profiling by means of DNA sequencer-assisted fluorophore-assisted carbohydrate electrophoresis. Methods in molecular biology (Clifton, N.J.), 1972, 235–250.
   PubMedGoogle Scholar
• Wang, X., et al., 2014. Overexpression of α (1,6) fucosyltransferase associated with aggressive prostate cancer. Glycobiology, 24 (10), 935–944.
   PubMed Web of Science ®Google Scholar
• Yaxley, J.W., et al., 2016. Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study. Lancet (London, England), 388 (10049), 1057–1066.
   PubMed Web of Science ®Google Scholar